NASDAQ:IOVA   Iovance Biotherapeutics, Inc.
was a good buy in the 30-32 range but i still think it's a buy here too, institutional interest, everyone likes it, i think it's headed to 40 within a month no prob unless the market tanks, also think it's good long term hold unless the story changes
評論:
tough news on this one, but this tends to happen with bios, still bullish but obviously will take some time to recover
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。